ArticleClinicoEconomics and outcomes research : CEOR2018

Relapse prevention: a cost-effectiveness analysis of brexpiprazole treatment in adult patients with schizophrenia in the USA.

Myrlene S Aigbogun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.